All articles by Phillip Broadwith – Page 22
-
Business
India revokes more pharma patents
Original molecule patent stands, but a new salt form is ‘not innovative’
-
BusinessGas specialist branches out into carbon nanotubes
Linde group launches ink made with long, individual tubes
-
Business
PolyOne to close six sites and shed 250 jobs
Former Spartech manufacturing facilities are ‘redundant’ after takeover in March
-
Business
Monsanto abandons GM crops in Europe
Company will focus on conventional plant breeding in EU and biotech elsewhere
-
Business
GSK under investigation over corruption in China
Police claim executives engaged in bribery and tax-related crimes
-
BusinessChemistry will underpin economic growth, say industry leaders
The UK chemical sector needs to rebuild supply chains and present a unified voice to government
-
PodcastImidacloprid
Phillip Broadwith discusses one of the neonicotinoid insecticides believed to be causing problems for bees
-
Business
Biosimilar drugs step up complexity
First generic monoclonal antibodies recommended for approval in Europe
-
Business
Data-sharing partnership for drug discovery
Collaborative project aims to assist medicinal chemistry efforts
-
Business
Ups and downs for erectile dysfunction drugs
First new drug in a decade approved in Europe as Viagra patent expires
-
PodcastResveratrol
Can a compound in red wine protect against heart attack and cancer? Phillip Broadwith investigates resveratrol
-
Research
Porous materials break out of covalent cage
Packing predictions open doors for new molecular sponges
-
Business
Companies urged to publish hidden clinical trial data
Researchers could acquire data and publish themselves if firms refuse
-
Business
Pfizer and Takeda win $2.15bn in patent payout
Teva and Sun fined for selling generics before patent expiry
-
Business
Big data to sniff out drug marketing fraud
US Food and Drug Administration wants to track promotional spending to spot off-label marketing